Article Details
Retrieved on: 2024-09-16 17:53:36
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Penumbra chief medical officer James Benenati said: “Based on outcomes from our clinical trials and physicians using our devices globally, our CAVT ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here